117 related articles for article (PubMed ID: 72427)
21. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
[TBL] [Abstract][Full Text] [Related]
22. Histocompatibility antigens (HLA) in multiple sclerosis in Iran.
Lotfi J; Nikbin B; Derakhshan I; Aghai Z; Ala F
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):699-701. PubMed ID: 681957
[TBL] [Abstract][Full Text] [Related]
23. HLA polymorphism in Israel. 6. North African Jews from Libya.
Bonné-Tamir B; Bodmer JG; Modai J
Tissue Antigens; 1978 Mar; 11(3):221-5. PubMed ID: 653715
[TBL] [Abstract][Full Text] [Related]
24. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
25. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.
Visscher BR; Sullivan CB; Detels R; Madden DL; Sever JL; Terasaki PI; Park MS; Dudley JP
Neurology; 1981 Sep; 31(9):1142-5. PubMed ID: 6267516
[TBL] [Abstract][Full Text] [Related]
26. HLA antigens in multiple sclerosis.
Thorsby E; Helgesen A; Solheim BG; Vandvik B
J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
[TBL] [Abstract][Full Text] [Related]
27. Histocompatibility types and measles antibodies in multiple sclerosis.
Fewster ME; Myers LW; Ellison GW; Walford RL
J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
[TBL] [Abstract][Full Text] [Related]
28. Mortality in two Jewish populations--Montreal and Israel: environmental determinants of differences.
Shatenstein B; Kark JD
Int J Epidemiol; 1995 Aug; 24(4):730-9. PubMed ID: 8550270
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.
Poskanzer DC; Sever JL; Terasaki PI; Prenney LB; Sheridan JL; Park MS
J Epidemiol Community Health; 1980 Dec; 34(4):265-70. PubMed ID: 7241025
[TBL] [Abstract][Full Text] [Related]
30. HLA antigens in two Iranian populations: the Armenians and the Jews.
Tabatabai H; Mohammad K; Mohagheghpour N
Tissue Antigens; 1978 Nov; 12(5):309-14. PubMed ID: 746530
[TBL] [Abstract][Full Text] [Related]
31. HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients.
Park MS; Terasaki PI; Ahmed AR; Tiwari JL
Lancet; 1979 Sep; 2(8140):441-2. PubMed ID: 89501
[TBL] [Abstract][Full Text] [Related]
32. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population.
Stewart GJ; Basten A; Kirk RL
Tissue Antigens; 1979 Aug; 14(2):86-97. PubMed ID: 91230
[TBL] [Abstract][Full Text] [Related]
33. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
[TBL] [Abstract][Full Text] [Related]
34. HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.
Paty DW; Dossetor JB; Stiller CR; Cousin HK; Marchuk L; Furesz J; Boucher DW
J Neurol Sci; 1977 Jul; 32(3):371-9. PubMed ID: 886362
[TBL] [Abstract][Full Text] [Related]
35. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.
Stendahl-Brodin L; Link H; Möller E; Norrby E
Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443
[TBL] [Abstract][Full Text] [Related]
36. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
[TBL] [Abstract][Full Text] [Related]
37. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
38. Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel.
Weintrob N; Sprecher E; Israel S; Pinhas-Hamiel O; Kwon OJ; Bloch K; Abramov N; Arbel A; Josefsberg Z; Brautbar C; Vardi P
Diabetes Care; 2001 Apr; 24(4):650-3. PubMed ID: 11315825
[TBL] [Abstract][Full Text] [Related]
39. Measles antibodies and histocompatibility types in multiple sclerosis.
Fewster ME; Ames FR; Botha MC
J Neurol Sci; 1979 Sep; 43(1):19-26. PubMed ID: 521827
[TBL] [Abstract][Full Text] [Related]
40. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
